Yahoo Web Search

Search results

    • 1 No-Brainer Growth Stock to Buy and Hold

      1 No-Brainer Growth Stock to Buy and Hold

      Motley Fool via Yahoo Finance· 20 hours ago

      At the very least, it indicates that the FDA likely has concerns regarding Eli Lilly's application -- specifically, the design of the clinical trial it...

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 4 days ago

      ...developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced that four scientific abstracts on its lead drug candidate, obefazimod, for the treatment of moderately to severely active ...

    • Veterans exposed to toxins deserve better

      Veterans exposed to toxins deserve better

      Real Change News· 4 days ago

      Toxic exposure at military bases has been overlooked for decades, but it can result in serious, often life-threatening illnesses for veterans. Over 700...